Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

Importance As the worldwide burden of endometrial cancer continues to rise, interest is
growing in the evaluation of early detection and prevention strategies among women at …

Background Incomplete excision of cervical precancer is associated with therapeutic failure
and is therefore considered as a quality indicator of clinical practice. Conversely, the risk of …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Objective To manage cervical screening abnormalities, the 2019 ASCCP management
consensus guidelines will recommend clinical action on the basis of risk of cervical …

Importance As cervical cancer screening transitions to primary human papillomavirus (HPV)
testing, effective triage and management of HPV-positive women is critical to avoid …

Anal cancer incidence and mortality have been increasing over the past decade. Although
the incidence in the general population remains low, it is much higher in certain subgroups …

Background HPV16/18 detection may improve cervical cancer risk stratification and better
guide which HPV-positive women warrant immediate colposcopy/biopsy. We estimated risks …

Background Probiotics has been shown to be effective in reducing vaginal colonization of
pathogenic organisms. The aim of this study was to investigate the influence of probiotic …

Background Women with atypical squamous cells of undetermined significance (ASC‐US)
can be triaged accurately with a high‐risk human papillomavirus (hrHPV) test to identify …